Loading...

Media

PUBLICATIONS

In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy

Volatile organic compounds (VOC)-based probes for predicting the efficacy of targeted chemotherapies

Targeting the tumor microenvironment hallmarks for pancreas and breast (TN) cancers chemotherapy

ADCs with high Drug Antibody Ratio

β-Galactosidase-responsive ADC for breast (HER2+) cancer chemotherapy

Small molecular weight drug delivery system to treat head and neck cancers

NEWS

Tech Tour Invest 2020: SEEKYO selected laureate by investors

Award Winner

International press coverage about SEEKYO

Capture

SEEKYO raises €800k with leverage effect

118FD417304B4CF181102B177E789510

SEEKYO’ cancer patients Charity campaign

Donation – MAIL

SEEKYO: A major advance against Cancer fight

Nouvelle Republique

SEEKYO and the DeepTech – BPI

BPI

SEEKYO certified Onco-Entrepreneur

5FB25DF4BE3B44BF8591CA9191AEC210

SEEKYO is awarded laureate of GENOPOLE Booster program

67822320_511065026387291_5271832658010177536_n